Skip to the main content

Letter to the Editor

A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis

Yuki Hayama ; Division of Dermatology, Daito Central Hospital Daito, Osaka, Japan
Hisayoshi Imanishi orcid id orcid.org/0000-0001-6930-5521 ; Division of Dermatology, Daito Central Hospital Daito, Osaka, Japan
Naoki Yoshimoto ; Department of Respiratory Medicine, Ishikiri Seiki Hospital, Higashiosaka, Osaka, Japan
Koji Sugawara ; Department of Dermatology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka, Japan
Daisuke Tsuruta ; Department of Dermatology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka, Japan


Full text: english pdf 94 Kb

page 249-250

downloads: 260

cite


Abstract

Dapsone is a dual-function drug with antimicrobial
and antiprotozoal effects and anti-inflammatory
features (1). In dermatology, it is a first choice for conditions
such as leprosy, IgA pemphigus, dermatitis
herpetiformis, and linear IgA bullous dermatosis, or
an adjunctive treatment for, e.g. bullous pemphigoid
(BP) and pemphigus vulgaris (1). However, dapsone is
associated with some adverse effects, including methemoglobinemia
(1).

Keywords

Hrčak ID:

255097

URI

https://hrcak.srce.hr/255097

Publication date:

30.12.2020.

Visits: 539 *